{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:47:17Z","timestamp":1793526437425,"version":"4.5.0"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u2018Fondo de Investigaciones Sanitarias\u2019 (Health Research Fund) of the Spanish Ministry of Health","award":["PI18\/00179"],"award-info":[{"award-number":["PI18\/00179"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Although nebulized liposomal amphotericin B (NLAB) is being used in invasive pulmonary aspergillosis (IPA) prophylaxis, no clinical trial has shown its efficacy as a therapeutic strategy. NAIFI is the inaugural randomized, controlled clinical trial designed to examine the safety and effectiveness of NLAB (dosage: 25 mg in 6 mL, three times per week for 6 weeks) against a placebo, in the auxiliary treatment of IPA. Throughout the three-year clinical trial, thirteen patients (six NLAB, seven placebo) were included, with 61% being onco-hematological with less than 100 neutrophils\/\u03bcL. There were no significant differences noted in their pre- and post-nebulization results of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and oxygen saturation between the groups. Neither bronchospasm nor serum amphotericin B levels were reported in any patients given NLAB. 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET-TC) was carried out at the baseline and after 6 weeks. A notable decrease in median SUV (standardized uptake value) was observed in NLAB patients after 6 weeks (\u22123.6 vs. \u22120.95, p: 0.039, one tail). Furthermore, a reduction in serum substance galactomannan and beta-D-Glucan was identified within NLAB recipients. NLAB is well tolerated and safe for patients with IPA. Encouraging indirect efficacy data have been derived from image monitoring or biomarkers. However, further studies involving more patients are necessary.<\/jats:p>","DOI":"10.3390\/jof10030191","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T06:07:53Z","timestamp":1709273273000},"page":"191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Phase I\/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6959-5263","authenticated-orcid":false,"given":"Jes\u00fas","family":"Fort\u00fan","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario \u201cRamon y Cajal\u201d, Avda Colmenar Km 9,1, 28034 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Medicine, Universidad Alcal\u00e1, 28801 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de 5 Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"G\u00f3mez-Garc\u00eda de la Pedrosa","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de 5 Salud Carlos III, 28029 Madrid, Spain"},{"name":"Department of Microbiology, Hospital Universitario \u201cRamon y Cajal\u201d, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mart\u00ednez-Lorca","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Nuclear Medicine, Hospital Universitario \u201cRamon y Cajal\u201d, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-5981","authenticated-orcid":false,"given":"Patricia","family":"Paredes","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Nuclear Medicine, Hospital Universitario \u201cRamon y Cajal\u201d, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mart\u00edn-D\u00e1vila","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario \u201cRamon y Cajal\u201d, Avda Colmenar Km 9,1, 28034 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de 5 Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"G\u00f3mez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de 5 Salud Carlos III, 28029 Madrid, Spain"},{"name":"Mycology Reference and Research Laboratory, Centro Nacional de Microbiolog\u00eda, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-6067","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Buitrago","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de 5 Salud Carlos III, 28029 Madrid, Spain"},{"name":"Mycology Reference and Research Laboratory, Centro Nacional de Microbiolog\u00eda, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"L\u00f3pez-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Medicine, Universidad Alcal\u00e1, 28801 Madrid, Spain"},{"name":"Department of Hematology, Hospital Universitario \u201cRamon y Cajal\u201d, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gioia","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario \u201cRamon y Cajal\u201d, Avda Colmenar Km 9,1, 28034 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5736-8111","authenticated-orcid":false,"given":"Rosa","family":"Escudero","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario \u201cRamon y Cajal\u201d, Avda Colmenar Km 9,1, 28034 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Medicine, Universidad Alcal\u00e1, 28801 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Alvarez-Alvarez","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario \u201cRamon y Cajal\u201d, Avda Colmenar Km 9,1, 28034 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-5365","authenticated-orcid":false,"given":"Cruz","family":"Soriano","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Intensive Care Unit, Hospital Universitario \u201cRamon y Cajal\u201d, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Moreno-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario \u201cRamon y Cajal\u201d, Avda Colmenar Km 9,1, 28034 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"San Miguel","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Pneumology, Hospital Universitario \u201cRamon y Cajal\u201d, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1123-0699","authenticated-orcid":false,"given":"Noelia","family":"Vicente","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Pharmacy, Hospital Universitario \u201cRamon y Cajal\u201d, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2843-1094","authenticated-orcid":false,"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario \u201cRamon y Cajal\u201d, Avda Colmenar Km 9,1, 28034 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital \u201cRam\u00f3n y Cajal\u201d (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Medicine, Universidad Alcal\u00e1, 28801 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de 5 Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2008.11.004","article-title":"Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: Pharmacokinetics and safety","volume":"28","author":"Monforte","year":"2009","journal-title":"J. Heart Lung Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2009.11.603","article-title":"Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation","volume":"29","author":"Monforte","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transpl. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pupt.2008.09.001","article-title":"Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: Data from a randomized placebo-controlled trial","volume":"21","author":"Slobbe","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102226","DOI":"10.1016\/j.pupt.2023.102226","article-title":"Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: A systematic review and meta- analysis","volume":"81","author":"Muthu","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-3062.2007.00290.x","article-title":"Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals","volume":"10","author":"Ho","year":"2008","journal-title":"Transpl. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"102233","DOI":"10.1016\/j.pupt.2023.102233","article-title":"Safety and usefulness of nebulized liposomal amphotericin B: Systematic scoping review","volume":"82","author":"Hagiya","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11046-019-00331-0","article-title":"Aerosolized Lipid Amphotericin B for Complementary Therapy and\/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience","volume":"184","author":"Venanzi","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/RCT.0b013e318289aa31","article-title":"(18)F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography findings are different between invasive and noninvasive pulmonary aspergillosis","volume":"37","author":"Kim","year":"2013","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13693780701639546","article-title":"The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections","volume":"46","author":"Chamilos","year":"2008","journal-title":"Med. Mycol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/cid\/ciz1195","article-title":"How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions","volume":"71","author":"Lewis","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/jps.24079","article-title":"Nebulization of active pharmaceutical ingredients with the eFlow(\u00ae) rapid: Impact of formulation variables on aerodynamic characteristics","volume":"103","author":"Oesterheld","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1179\/joc.2007.19.3.339","article-title":"Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder","volume":"19","author":"Castagnola","year":"2007","journal-title":"J. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.riam.2011.06.005","article-title":"Traqueobronquitis aspergilar en paciente sometido a trasplante pulmonar [Aspergillus tracheobronchitis in a lung transplant recipient]","volume":"28","year":"2011","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.201311-2086LE","article-title":"Nebulized liposomal amphotericin B for treating Aspergillus empyema with bronchopleural fistula","volume":"189","author":"Hanada","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/myc.12294","article-title":"Nebulised liposomal amphotericin B for Aspergillus lung diseases: Case series and literature review","volume":"58","author":"Godet","year":"2015","journal-title":"Mycoses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2169\/internalmedicine.6305-20","article-title":"Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis","volume":"60","author":"Hamada","year":"2021","journal-title":"Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e13501","DOI":"10.1111\/tid.13501","article-title":"Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient","volume":"23","author":"Trujillo","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11046-015-9891-4","article-title":"Treatment of Disseminated Talaromyces marneffei with Tracheal Infection: Two Case Reports","volume":"180","author":"Qiu","year":"2015","journal-title":"Mycopathologia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.transproceed.2009.06.018","article-title":"A comparision of several formats of amphotericin B as an inhaled antifungal prophylaxis","volume":"41","author":"Morales","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.healun.2012.11.013","article-title":"Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant","volume":"32","author":"Monforte","year":"2013","journal-title":"J. Heart Lung Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/tid.12492","article-title":"Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients","volume":"18","author":"Peghin","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e13448","DOI":"10.1111\/tid.13448","article-title":"Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation","volume":"23","author":"Linder","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Rutsaert","year":"2021","journal-title":"Crit. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"874117","DOI":"10.3389\/fonc.2022.874117","article-title":"Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)","volume":"12","author":"Malagola","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e13832","DOI":"10.1111\/tid.13832","article-title":"Antifungal prophylaxis in adult lung transplant recipients: Uncertainty despite 30 years of experience. A systematic review of the literature and network meta-analysis","volume":"24","author":"Marinelli","year":"2022","journal-title":"Transpl. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000327802","article-title":"Prophylactic application of nebulized liposomal amphotericin B in hematologic patients with neutropenia","volume":"34","author":"Holler","year":"2011","journal-title":"Onkologie"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ankrah, A.O., Creemers-Schild, D., De Keizer, B., Klein, H.C., Dierckx, R.A., Kwee, T.C., Span, L.F., De Jong, P.A., Sathekge, M.M., and Glaudemans, A.W. (2021). The Added Value of [18F]FDG PET\/CT in the Management of Invasive Fungal Infections. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010137"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00259-018-4062-8","article-title":"FDG PET\/CT imaging in detecting and guiding management of invasive fungal infections: A retrospective comparison to conventional CT imaging","volume":"46","author":"Douglas","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Calero, A.L., Alonso, R., Gadea, I., Vega, M.D.M., Garc\u00eda, M.M., Mu\u00f1oz, P., Machado, M., Bouza, E., and Garc\u00eda-Rodr\u00edguez, J. (2022). Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02626-21"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rombauts, A., Bodro, M., Daniel Gumucio, V., Carbonell, I., Fav\u00e0, \u00c0., Llado, L., Gonz\u00e1lez-Costello, J., Oppenheimer, F., Castel-Lavilla, M.\u00c1., and Len, O. (2023). Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: A retrospective observational study. Front. Cell Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1165236"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00134-021-06603-y","article-title":"Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis","volume":"48","author":"Soriano","year":"2022","journal-title":"Intensive Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/phar.1309","article-title":"Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation","volume":"33","author":"Safdar","year":"2013","journal-title":"Pharmacotherapy"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0b013e3181f995ea","article-title":"Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients","volume":"90","author":"Husain","year":"2010","journal-title":"Transplantation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/myc.13591","article-title":"Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open-label randomized controlled trial","volume":"66","author":"Muthu","year":"2023","journal-title":"Mycoses"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101975","DOI":"10.1016\/j.pupt.2020.101975","article-title":"Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles\/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery","volume":"64","author":"Gomez","year":"2020","journal-title":"Pulm. Pharmacol. Ther."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/3\/191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:07:54Z","timestamp":1760105274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/3\/191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["jof10030191"],"URL":"https:\/\/doi.org\/10.3390\/jof10030191","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}